Skip to main content

COVID-19 pandemic has 'severely' tested resilience of all nations, says PM Modi during UN ECOSOC address

Date – 17/07/2020

Source – Moneycontrol

The prime minister said India has ensured one of the best recovery rates in the world

 

Prime Minister Narendra Modi, while addressing a high-level segment of the UN Economic and Social Council (ECOSOC) via video conferencing, said that the novel coronavirus, or COVID-19, pandemic has 'severely tested' resilience of all nations.

"COVID-19 pandemic has severely tested the resilience of all nations. In India, we have tried to make the fight against the pandemic a people's movement, by combining the efforts of the government and civil society," the prime minister said during his address, adding that India has ensured one of the best recovery rates in the world.

The prime minister said India has provided medical and other assistance to over 150 countries.



"The United Nations (UN) was originally born from the furies of the Second World War. Today, the fury of the pandemic provides the context for its rebirth and reform. Let us not lose this chance," the prime minister said.

PM Modi said India's motto is 'Sabka saath, sabka vikas', which "resonates with the core Sustainable Development Goals principle of leaving no one behind."

"Today, through our domestic efforts, we are again playing a salient role in achieving Agenda 2030 and the Sustainable Development Goals. We are also supporting other developing countries in meeting their Sustainable Development Goals," PM Modi said.

"India is home to one-sixth of humanity. We are mindful of our weight and responsibility. We know that if India succeeds in achieving its development objectives, it will go a long way in achievement of global goals," PM Modi said, adding that India has supported the UN's development work since the 'very beginning'.

"The first president of ECOSOC was an Indian. India also contributed to shaping the ECOSOC agenda," PM Modi said.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more